Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(
1
)
Home
|
Portfolio
|
Market Currents
|
Investing Ideas
|
Dividends & Income
|
ETFs
|
Macro View
|
ALERTS
|
PRO
This Market Current was sent to
418
people who get email alerts on SNPS.
Get email alerts on SNPS »
Market Currents
All
Top Stories
Breaking News
On the Move
Quick Ideas
Earnings
Dividends
M&A
U.S. Economy
Global & FX
Commodities
ETFs
Tech
Consumer
Energy
Financials
Healthcare
Synopsys (SNPS): FQ1 EPS of $0.50 beats by $0.09. Revenue of $340M (+7.7%) vs. $335M. Shares...
Wednesday, February 18, 2009, 6:01 PM ET
Synopsys (
SNPS
):
FQ1 EPS of $0.50
beats by $0.09
. Revenue of $340M (+7.7%) vs. $335M. Shares
+3.1%
AH. (
PR
)
This Market Current was sent to
418
people who get email alerts on SNPS.
Get email alerts on SNPS »
Share this Market Current
Short URL:
Tweet
Load All Comments
LATEST
|
TODAY SO FAR
|
YESTERDAY
Other date
DJIA (
DIA
)
S&P 500 (
SPY
)
Latest Articles
Triumph Group: The Growth Story Continues
3:52 AM
•
Fusion Research
American Capital Agency's Dividend Cut Is Good News For mREIT Investors
3:49 AM
•
CorvetteKid
Applied Micro: Upcoming Catalyst Should Drive Significant Downside After Irrational Rally
3:36 AM
•
Ashraf Eassa
Investors Title Company Will Continue To Build Its Intrinsic Value With A Strong Housing Market
3:31 AM
•
Tim Travis
EUR/USD Technical Set Up Favors Further Upside Ahead Of FOMC
3:29 AM
•
FXstreet
Danger Zone For This Week: Citigroup
3:21 AM
•
David Trainer
Unintended Consequences Of Bernanke's Fed Hedge Fund
2:59 AM
•
Jason Schwarz
First Solar: Now Comes The Hard Part
2:27 AM
•
Bill Maurer
Starbucks Has Tremendous Opportunities Overseas
1:58 AM
•
Saibus Research
Canadian Banks Cannot Escape The Effects Of A Housing Market Bubble And A Slowing Economy
1:42 AM
•
Junius
Campbell's Justifies High P/E With Acquisitions And International Growth
1:38 AM
•
Chris Katje
Add A Faucet To Your DRIP
1:27 AM
•
Adam Aloisi
Micron: The BIG One For Wednesday
12:26 AM
•
Russ Fischer
American Medical Association Decision Can Boost Arena, Vivus, And Orexigen
12:22 AM
•
Spencer Osborne
The Full Story On Dole: Why The $12.00 MBO Is Too Cheap And How We Get More Value
8:19 PM
•
Mike Winston
More Latest Articles »